ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
Unlocking Diversity of Biologically Relevant Quinoline Scaffolds by Leveraging the Readily Available Feedstocks Under Cobalt-NHC Catalysis.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Quinolines are privileged heterocycles with widespread applications in pharmaceuticals, agrochemicals, and materials science. However, sustainable and efficient one-pot methods for synthesizing and functionalizing quinolines, e.g., 2-methyl/aminoquinoline derivatives remained scarce. Herein, we report a unified, green, and operationally simple one-pot strategy, which is enabled by a multitasking Co-NHC catalyst (Co3). Starting from 2-aminobenzyl alcohol and acetone or benzyl nitrile as reactant, the present method achieves selective cyclization under open-air conditions to afford 2-methyl or 2-aminoquinolines, respectively. Remarkably, the same catalytic system enables divergent C(sp
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.